211 related articles for article (PubMed ID: 24064216)
21. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
[TBL] [Abstract][Full Text] [Related]
22. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Lee TD; Lee OW; Brimacombe KR; Chen L; Guha R; Lusvarghi S; Tebase BG; Klumpp-Thomas C; Robey RW; Ambudkar SV; Shen M; Gottesman MM; Hall MD
Mol Pharmacol; 2019 Nov; 96(5):629-640. PubMed ID: 31515284
[TBL] [Abstract][Full Text] [Related]
23. Binding Site Interactions of Modulators of Breast Cancer Resistance Protein, Multidrug Resistance-Associated Protein 2, and P-Glycoprotein Activity.
Deng F; Ghemtio L; Grazhdankin E; Wipf P; Xhaard H; Kidron H
Mol Pharm; 2020 Jul; 17(7):2398-2410. PubMed ID: 32496785
[TBL] [Abstract][Full Text] [Related]
24. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.
Cisternino S; Mercier C; Bourasset F; Roux F; Scherrmann JM
Cancer Res; 2004 May; 64(9):3296-301. PubMed ID: 15126373
[TBL] [Abstract][Full Text] [Related]
25. Human-Mouse Chimeras with Normal Expression and Function Reveal That Major Domain Swapping Is Tolerated by P-Glycoprotein (ABCB1).
Pluchino KM; Hall MD; Moen JK; Chufan EE; Fetsch PA; Shukla S; Gill DR; Hyde SC; Xia D; Ambudkar SV; Gottesman MM
Biochemistry; 2016 Feb; 55(7):1010-23. PubMed ID: 26820614
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of GRP78/BiP in P-Glycoprotein-Positive L1210 Cells is Responsible for Altered Response of Cells to Tunicamycin as a Stressor of the Endoplasmic Reticulum.
Šereš M; Pavlíková L; Boháčová V; Kyca T; Borovská I; Lakatoš B; Breier A; Sulová Z
Cells; 2020 Apr; 9(4):. PubMed ID: 32268491
[TBL] [Abstract][Full Text] [Related]
27. Suppressor mutations in the transmembrane segments of P-glycoprotein promote maturation of processing mutants and disrupt a subset of drug-binding sites.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2007 Nov; 282(44):32043-52. PubMed ID: 17848563
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of multidrug resistance by adamantylgb3, a globotriaosylceramide analog.
De Rosa MF; Ackerley C; Wang B; Ito S; Clarke DM; Lingwood C
J Biol Chem; 2008 Feb; 283(8):4501-11. PubMed ID: 18003606
[TBL] [Abstract][Full Text] [Related]
29. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells.
Kanagasabai R; Krishnamurthy K; Druhan LJ; Ilangovan G
J Biol Chem; 2011 Sep; 286(38):33289-300. PubMed ID: 21784846
[TBL] [Abstract][Full Text] [Related]
30. Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1).
He SM; Li R; Kanwar JR; Zhou SF
Curr Med Chem; 2011; 18(3):439-81. PubMed ID: 21143116
[TBL] [Abstract][Full Text] [Related]
31. Identification of residues in the drug translocation pathway of the human multidrug resistance P-glycoprotein by arginine mutagenesis.
Loo TW; Bartlett MC; Clarke DM
J Biol Chem; 2009 Sep; 284(36):24074-87. PubMed ID: 19581304
[TBL] [Abstract][Full Text] [Related]
32. ABCB1 single nucleotide polymorphisms (1236C>T, 2677G>T, and 3435C>T) do not affect transport activity of human P-glycoprotein.
Dickens D; Owen A; Alfirevic A; Pirmohamed M
Pharmacogenet Genomics; 2013 Jun; 23(6):314-23. PubMed ID: 23619510
[TBL] [Abstract][Full Text] [Related]
33. Conserved Walker A cysteines 431 and 1074 in human P-glycoprotein are accessible to thiol-specific agents in the apo and ADP-vanadate trapped conformations.
Sim HM; Bhatnagar J; Chufan EE; Kapoor K; Ambudkar SV
Biochemistry; 2013 Oct; 52(41):7327-38. PubMed ID: 24053441
[TBL] [Abstract][Full Text] [Related]
34. Effects of MDR1 1236C > T-2677G > T-3435C > T polymorphisms on the intracellular accumulation of tacrolimus, cyclosporine A, sirolimus and everolimus.
Wang R; Sun X; Deng YS; Qiu XW
Xenobiotica; 2019 Nov; 49(11):1373-1378. PubMed ID: 30587068
[TBL] [Abstract][Full Text] [Related]
35. The Transmission Interfaces Contribute Asymmetrically to the Assembly and Activity of Human P-glycoprotein.
Loo TW; Clarke DM
J Biol Chem; 2015 Jul; 290(27):16954-63. PubMed ID: 25987565
[TBL] [Abstract][Full Text] [Related]
36. Constitutive overexpression of P-glycoprotein, rather than breast cancer resistance protein or organic cation transporter 1, contributes to acquisition of imatinib-resistance in K562 cells.
Hirayama C; Watanabe H; Nakashima R; Nanbu T; Hamada A; Kuniyasu A; Nakayama H; Kawaguchi T; Saito H
Pharm Res; 2008 Apr; 25(4):827-35. PubMed ID: 17934801
[TBL] [Abstract][Full Text] [Related]
37. A human lymphocyte based ex vivo assay to study the effect of drugs on P-glycoprotein (P-gp) function.
Parasrampuria DA; Lantz MV; Benet LZ
Pharm Res; 2001 Jan; 18(1):39-44. PubMed ID: 11336351
[TBL] [Abstract][Full Text] [Related]
38. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.
Zhou SF
Xenobiotica; 2008 Jul; 38(7-8):802-32. PubMed ID: 18668431
[TBL] [Abstract][Full Text] [Related]
39. Multidrug resistance-associated protein 2 (MRP2/ABCC2) haplotypes significantly affect the pharmacokinetics of tacrolimus in kidney transplant recipients.
Ogasawara K; Chitnis SD; Gohh RY; Christians U; Akhlaghi F
Clin Pharmacokinet; 2013 Sep; 52(9):751-62. PubMed ID: 23633119
[TBL] [Abstract][Full Text] [Related]
40. ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS.
Daood M; Tsai C; Ahdab-Barmada M; Watchko JF
Neuropediatrics; 2008 Aug; 39(4):211-8. PubMed ID: 19165709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
